These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

351 related articles for article (PubMed ID: 25275135)

  • 41. A patch of positively charged amino acids surrounding the human immunodeficiency virus type 1 Vif SLVx4Yx9Y motif influences its interaction with APOBEC3G.
    Chen G; He Z; Wang T; Xu R; Yu XF
    J Virol; 2009 Sep; 83(17):8674-82. PubMed ID: 19535450
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Vif hijacks CBF-β to degrade APOBEC3G and promote HIV-1 infection.
    Jäger S; Kim DY; Hultquist JF; Shindo K; LaRue RS; Kwon E; Li M; Anderson BD; Yen L; Stanley D; Mahon C; Kane J; Franks-Skiba K; Cimermancic P; Burlingame A; Sali A; Craik CS; Harris RS; Gross JD; Krogan NJ
    Nature; 2011 Dec; 481(7381):371-5. PubMed ID: 22190037
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Differential requirement for conserved tryptophans in human immunodeficiency virus type 1 Vif for the selective suppression of APOBEC3G and APOBEC3F.
    Tian C; Yu X; Zhang W; Wang T; Xu R; Yu XF
    J Virol; 2006 Mar; 80(6):3112-5. PubMed ID: 16501124
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Possible footprints of APOBEC3F and/or other APOBEC3 deaminases, but not APOBEC3G, on HIV-1 from patients with acute/early and chronic infections.
    Armitage AE; Deforche K; Welch JJ; Van Laethem K; Camacho R; Rambaut A; Iversen AK
    J Virol; 2014 Nov; 88(21):12882-94. PubMed ID: 25165112
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Running loose or getting lost: how HIV-1 counters and capitalizes on APOBEC3-induced mutagenesis through its Vif protein.
    Münk C; Jensen BE; Zielonka J; Häussinger D; Kamp C
    Viruses; 2012 Nov; 4(11):3132-61. PubMed ID: 23202519
    [TBL] [Abstract][Full Text] [Related]  

  • 46. A single amino acid in human APOBEC3F alters susceptibility to HIV-1 Vif.
    Albin JS; LaRue RS; Weaver JA; Brown WL; Shindo K; Harjes E; Matsuo H; Harris RS
    J Biol Chem; 2010 Dec; 285(52):40785-92. PubMed ID: 20971849
    [TBL] [Abstract][Full Text] [Related]  

  • 47. MDM2 is a novel E3 ligase for HIV-1 Vif.
    Izumi T; Takaori-Kondo A; Shirakawa K; Higashitsuji H; Itoh K; Io K; Matsui M; Iwai K; Kondoh H; Sato T; Tomonaga M; Ikeda S; Akari H; Koyanagi Y; Fujita J; Uchiyama T
    Retrovirology; 2009 Jan; 6():1. PubMed ID: 19128510
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Endogenous origins of HIV-1 G-to-A hypermutation and restriction in the nonpermissive T cell line CEM2n.
    Refsland EW; Hultquist JF; Harris RS
    PLoS Pathog; 2012; 8(7):e1002800. PubMed ID: 22807680
    [TBL] [Abstract][Full Text] [Related]  

  • 49. HIV-1 Vif interaction with APOBEC3 deaminases and its characterization by a new sensitive assay.
    Cadima-Couto I; Saraiva N; Santos AC; Goncalves J
    J Neuroimmune Pharmacol; 2011 Jun; 6(2):296-307. PubMed ID: 21279453
    [TBL] [Abstract][Full Text] [Related]  

  • 50. A novel HIV-1 restriction factor that is biologically distinct from APOBEC3 cytidine deaminases in a human T cell line CEM.NKR.
    Zhou T; Han Y; Dang Y; Wang X; Zheng YH
    Retrovirology; 2009 Apr; 6():31. PubMed ID: 19344514
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Regulation of APOBEC3 proteins by a novel YXXL motif in human immunodeficiency virus type 1 Vif and simian immunodeficiency virus SIVagm Vif.
    Pery E; Rajendran KS; Brazier AJ; Gabuzda D
    J Virol; 2009 Mar; 83(5):2374-81. PubMed ID: 19109396
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Ubiquitination of APOBEC3 proteins by the Vif-Cullin5-ElonginB-ElonginC complex.
    Shirakawa K; Takaori-Kondo A; Kobayashi M; Tomonaga M; Izumi T; Fukunaga K; Sasada A; Abudu A; Miyauchi Y; Akari H; Iwai K; Uchiyama T
    Virology; 2006 Jan; 344(2):263-6. PubMed ID: 16303161
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Core binding factor beta plays a critical role by facilitating the assembly of the Vif-cullin 5 E3 ubiquitin ligase.
    Fribourgh JL; Nguyen HC; Wolfe LS; Dewitt DC; Zhang W; Yu XF; Rhoades E; Xiong Y
    J Virol; 2014 Mar; 88(6):3309-19. PubMed ID: 24390320
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Polyubiquitination of APOBEC3G is essential for its degradation by HIV-1 Vif.
    Shao Q; Wang Y; Hildreth JE; Liu B
    J Virol; 2010 May; 84(9):4840-4. PubMed ID: 20147392
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Natural polymorphisms in human APOBEC3H and HIV-1 Vif combine in primary T lymphocytes to affect viral G-to-A mutation levels and infectivity.
    Refsland EW; Hultquist JF; Luengas EM; Ikeda T; Shaban NM; Law EK; Brown WL; Reilly C; Emerman M; Harris RS
    PLoS Genet; 2014 Nov; 10(11):e1004761. PubMed ID: 25411794
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The assembly of Vif ubiquitin E3 ligase for APOBEC3 degradation.
    Kim DY
    Arch Pharm Res; 2015 Apr; 38(4):435-45. PubMed ID: 25408426
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Direct inhibition of human APOBEC3 deaminases by HIV-1 Vif independent of the proteolysis pathway.
    Kamba K; Wan L; Unzai S; Morishita R; Takaori-Kondo A; Nagata T; Katahira M
    Biophys J; 2024 Feb; 123(3):294-306. PubMed ID: 38115583
    [TBL] [Abstract][Full Text] [Related]  

  • 58. ARIH2 Is a Vif-Dependent Regulator of CUL5-Mediated APOBEC3G Degradation in HIV Infection.
    Hüttenhain R; Xu J; Burton LA; Gordon DE; Hultquist JF; Johnson JR; Satkamp L; Hiatt J; Rhee DY; Baek K; Crosby DC; Frankel AD; Marson A; Harper JW; Alpi AF; Schulman BA; Gross JD; Krogan NJ
    Cell Host Microbe; 2019 Jul; 26(1):86-99.e7. PubMed ID: 31253590
    [TBL] [Abstract][Full Text] [Related]  

  • 59. A naturally occurring Vif mutant (I107T) attenuates anti-APOBEC3G activity and HIV-1 replication.
    Peng J; Ao Z; Matthews C; Wang X; Ramdahin S; Chen X; Li J; Chen L; He J; Ball B; Fowke K; Plummer F; Embree J; Yao X
    J Mol Biol; 2013 Aug; 425(16):2840-52. PubMed ID: 23707381
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Identification of 81LGxGxxIxW89 and 171EDRW174 domains from human immunodeficiency virus type 1 Vif that regulate APOBEC3G and APOBEC3F neutralizing activity.
    Dang Y; Davis RW; York IA; Zheng YH
    J Virol; 2010 Jun; 84(11):5741-50. PubMed ID: 20335268
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.